Latest Tomotherapy Stories
More than 300 members of Europe's radiation oncology community attended a TomoTherapy(SM)-focused symposium on Tuesday, Sept. 16, 2008 in Gothenburg, Sweden. The Advanced Clinical Solutions Symposium was hosted by TomoTherapy Incorporated (NASDAQ: TOMO), maker of the Hi-Art(R) treatment system, and held during the European Society for Therapeutic Radiology and Oncology (ESTRO) annual meeting. Four eminent clinical experts, including ESTRO president Prof. Vincent Gregoire, discussed the...
Thousands of cancer patients in need of proton therapy--a form of radiation therapy without many of the short- and long-term side effects-- can look forward to having a treatment center available in Illinois with the 4-0 approval today by the Illinois Health Facilities Planning Board (IHFPB) of the Proton Therapy Center of Central DuPage Hospital. Construction on the 58,000-square-foot, state-of-the-art proton therapy treatment center in Warrenville's Cantera development will begin...
Varian Medical Systems, a manufacturer of medical devices and software, has announced that the Ghent University Hospital in Belgium is acquiring the company's RapidArc technology for fast and efficient modulated arc therapy treatments for cancer patients. According to Varian Medical Systems, RapidArc delivers a volumetric intensity-modulated radiation therapy treatment in a single or multiple arcs of the treatment machine around the patient and makes it possible to deliver advanced...
SUNNYVALE, Calif., Sept. 11 /PRNewswire-FirstCall/ -- Pharmacyclics, Inc. (the "Company" or "Pharmacyclics") announced today that Christine A. White, M.D., Richard M. Levy Ph.D., Mr. Miles R. Gilburne and Richard A. Miller, M.D. have resigned as members of the Board of Directors of the Company, effective immediately. The remaining members of the Board of Directors, consisting of Mr. Robert W. Duggan and Mr. James L. Knighton, appointed Minesh Mehta, M.D. and Glenn C. Rice, Ph.D. to the...
TomoTherapy Incorporated (NASDAQ: TOMO) today announced that Azienda Ospedaliero - Universitaria di Modena in Modena, Italy has selected the Hi-Art(R) treatment system for advanced radiation therapy. The leading Italian hospital was able to make this revolutionary technology available to regional cancer patients less than a month after receiving the system. Stefano Cencetti, MD, Executive Director of Azienda Ospedaliero - Universitaria di Modena, explained, "Thanks to the perfect...
TomoTherapy Incorporated (NASDAQ: TOMO) announced today that it has partnered with Vision RT to expand imaging options for Hi-Art(R) treatment system users. The companies will jointly introduce AlignRT(R) 3D imaging technology for the Hi-Art platform at the annual meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO) in Boston, Mass., Sept. 21-25, 2008. TomoTherapy will distribute AlignRT(R) for use with both its TomoHelical(TM) and new TomoDirect(TM) delivery modes....
SUNNYVALE, Calif., Sept. 4 /PRNewswire/ -- Xoft, Inc., developer of the Axxent(R) Electronic Brachytherapy (eBx) System, a proprietary cancer treatment platform that utilizes X-rays to deliver non-radioactive, isotope- free radiation therapy directly to cancer sites, today announced that it will present at the 2008 Citi Investment Research Emerging Medical Technology Conference on Radiation Oncology. Xoft president and CEO, Michael Klein, will present on September 4 at 1:30 pm at the Citi...
TomoTherapy has received the FDA 510(k) clearance for its TomoDirect radiation therapy technology. TomoDirect is an innovative new discrete-angle, sliding-beam delivery mode for the HiArt treatment system. With this capability, clinicians are said to gain an efficient complement to helical TomoTherapy, one that enables fast treatment planning and delivery, while broadening the spectrum of patients that can be optimally treated with the advanced platform for cancer care. According to the...
TomoTherapy Incorporated (NASDAQ: TOMO) today announced that it has received FDA 510(k) clearance for its TomoDirect(TM) radiation therapy technology. TomoDirect is an innovative new discrete-angle, sliding-beam delivery mode for the Hi-Art(R) treatment system. With this capability, clinicians gain an efficient complement to helical TomoTherapy(SM), one that enables fast treatment planning and delivery, while broadening the spectrum of patients that can be optimally treated with the...
PLAINSBORO, N.J., Aug. 20, 2008 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that Radionics(R) XKnife(R) clinicians presented their latest advances in the treatment of brain and spine tumors on Sunday, July 27th at the 50th annual meeting of the American Association of Physicists in Medicine in Houston, Texas. The Radionics(R) XKnife(R) radiosurgery system is developed, manufactured, and marketed by Integra LifeSciences Holdings Corporation,...
